Krug, S.; Khosravian, M.; Weissbach, J.; George, K.; Damm, M.; Garbe, J.; Walldorf, J.; Reuken, P.A.; Amin, T.; Siebenhüner, A.;
et al. The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers 2022, 14, 613.
https://doi.org/10.3390/cancers14030613
AMA Style
Krug S, Khosravian M, Weissbach J, George K, Damm M, Garbe J, Walldorf J, Reuken PA, Amin T, Siebenhüner A,
et al. The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers. 2022; 14(3):613.
https://doi.org/10.3390/cancers14030613
Chicago/Turabian Style
Krug, Sebastian, Maryam Khosravian, Julia Weissbach, Katharina George, Marko Damm, Jakob Garbe, Jens Walldorf, Philipp A. Reuken, Tania Amin, Alexander Siebenhüner,
and et al. 2022. "The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease" Cancers 14, no. 3: 613.
https://doi.org/10.3390/cancers14030613
APA Style
Krug, S., Khosravian, M., Weissbach, J., George, K., Damm, M., Garbe, J., Walldorf, J., Reuken, P. A., Amin, T., Siebenhüner, A., Rosendahl, J., Gress, T. M., Michl, P., Schrader, J., & Rinke, A.
(2022). The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers, 14(3), 613.
https://doi.org/10.3390/cancers14030613